Search results
USPTO Publishes Drug Patent and Exclusivity Study Report
The National Law Review· 12 hours agoThe stated purpose of the report is “to provide a baseline approach that researchers and...
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu...
Fortune via Yahoo Finance· 16 hours agoIt pointed out that ASPR...Bright says, is to urgently place orders for fresh drugs, refresh long...
Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit Lawsuit
Forbes· 5 days agoThe company says some wellness centers and websites are selling unauthorized and counterfeit...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 6 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
What Is the Safest ED Medication?
MediaFeed via AOL· 22 hours agoSafety is an essential factor to consider before using any type of medication, and treatments for ED are no exception. Luckily, ED is a treatable issue...
Why COVID patients who could most benefit from Paxlovid still aren’t getting it
Daily Montanan via Yahoo News· 21 hours agoEvangelical minister Eddie Hyatt believes in the healing power of prayer but “also the medical...
Health Care Week in Review: Senate Democrats Released Draft Legislation to Prevent Labor and...
JD Supra· 1 day agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
Eli Lilly is cracking down on knock-off versions of its popular weight loss drug Zepbound
Quartz· 5 days agoEli Lilly said Thursday that it is taking legal action against six entities for selling unapproved...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 4 days agoThe stock has risen 453% in the past five years, mainly on the success of its drug semaglutide, a...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 5 days agoMeanwhile, sales from blockbuster insulins Humalog and Humulin are expected to fall now that Lilly...